StockNews.com assumed coverage on shares of Stericycle (NASDAQ:SRCL – Get Free Report) in a research report issued on Wednesday. The brokerage set a “hold” rating on the business services provider’s stock.
Several other analysts have also weighed in on SRCL. Truist Financial boosted their target price on shares of Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a research note on Tuesday, June 4th. Keefe, Bruyette & Woods boosted their price objective on shares of Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a research report on Tuesday, June 4th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $62.00 price objective (down previously from $69.00) on shares of Stericycle in a research note on Tuesday, June 4th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, Stericycle presently has an average rating of “Hold” and an average price target of $74.00.
Check Out Our Latest Stock Report on SRCL
Stericycle Trading Down 0.9 %
Shares of SRCL stock traded down $0.58 during trading hours on Wednesday, hitting $61.13. 4,638,695 shares of the company were exchanged, compared to its average volume of 1,125,355. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.13 and a current ratio of 1.13. Stericycle has a one year low of $37.78 and a one year high of $61.77. The business’s 50-day simple moving average is $59.47 and its two-hundred day simple moving average is $54.99.
Stericycle (NASDAQ:SRCL – Get Free Report) last released its earnings results on Thursday, July 25th. The business services provider reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.04. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. The company had revenue of $661.60 million for the quarter, compared to the consensus estimate of $672.07 million. On average, equities research analysts forecast that Stericycle will post 2.29 EPS for the current year.
Institutional Trading of Stericycle
Several hedge funds have recently bought and sold shares of SRCL. Clearstead Trust LLC bought a new stake in Stericycle during the first quarter worth approximately $25,000. International Assets Investment Management LLC purchased a new position in Stericycle during the 2nd quarter valued at about $45,000. GAMMA Investing LLC grew its position in Stericycle by 170.9% during the first quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock valued at $43,000 after purchasing an additional 516 shares in the last quarter. Headlands Technologies LLC acquired a new position in shares of Stericycle in the first quarter worth $44,000. Finally, TFO Wealth Partners LLC increased its position in Stericycle by 22,325.0% in the 4th quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock worth $44,000 after purchasing an additional 893 shares during the last quarter. 98.82% of the stock is currently owned by institutional investors.
Stericycle Company Profile
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
Recommended Stories
- Five stocks we like better than Stericycle
- How to invest in marijuana stocks in 7 steps
- Analyst Think There’s Still Time to Get in on Edgewise, Up 332%
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Stocks Raising Dividends 4X Higher Than Inflation
- How to Use the MarketBeat Dividend Calculator
- Palantir Stock Joins the S&P 500; Is It Time to Buy?
Should you invest $1,000 in Stericycle right now?
Before you consider Stericycle, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Stericycle wasn’t on the list.
While Stericycle currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
